Patent Ethics CLE

conflict

Avoiding Common Conflicts of Interest in IP Law Practice – CNA Webinar Series

Avoiding Common Conflicts of Interest in IP Law Practice by Michael E. McCabe, Jr. CNA Intellectual Property/Lawyers Professional Liability Webinar Series: 2019 IP Ethics and Risk Management Update 2:00 – 4:00 PM ET March 27, 2019

Avoiding Common Conflicts of Interest in IP Law Practice – CNA Webinar Series Read More »

tanner daniels 111267 unsplash

CincyIP 2018 – The Ethics of Legal Process Outsourcing for the IP Attorney

CincyIP 2018  – Cincinnati Intellectual Property Law Association The Ethics of Legal Process Outsourcing for the IP Attorney by Michael E. McCabe, Jr. 11:45 am – 1:00 pm CT December 11, 2018 The Cincinnatian Hotel Cincinnati, OH One (1) hour ethics CLE

CincyIP 2018 – The Ethics of Legal Process Outsourcing for the IP Attorney Read More »

Ethics

American Conference Institute’s 4th Annual Post-Grant PTO Proceedings: Exploring Ethical Requirements in the Patent and Trademark Process

American Conference Institute’s 4th Annual Post-Grant PTO Proceedings Exploring Ethical Requirements When Working Through the Patent and Trademark Process – featuring Michael E. McCabe, Jr. (McCabe Law), Donald H. Heckenberg, Jr. (Fitzpatrick Cello) and the Honorable Teresa Rea (Crowell & Moring) July 18, 2018 from 1:30 – 2:30 PM EDT Washington, D.C. One (1) hour of

American Conference Institute’s 4th Annual Post-Grant PTO Proceedings: Exploring Ethical Requirements in the Patent and Trademark Process Read More »

tiphaine 27140 unsplash

ACI 9th Annual Summit On Biosimilars: Evaluating Ethical Concerns for the Biologics Industry

American Conference Institute’s 9th Annual Summit on Biosimilars Evaluating Ethical Concerns for the Biologics Industry – featuring Michael E. McCabe, Jr. (McCabe Law), Mark Waddell (Loeb & Loeb) & the Honorable Teresa Rea (Crowell & Moring) June 26, 2018 from 4:00 – 5:00 PM EST New York, NY One (1) hour of ethics CLE

ACI 9th Annual Summit On Biosimilars: Evaluating Ethical Concerns for the Biologics Industry Read More »

Scroll to Top